- 首頁
- App 分析
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. Multiple Myeloma [MM]
Multiple Myeloma Management 與 Multiple Myeloma [MM] 使用情況與統計
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Multiple Myeloma @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Multiple Myeloma content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Multiple Myeloma Management與 Multiple Myeloma [MM] 比較排名
比較過去 28 天的 Multiple Myeloma Management 排名趨勢與 Multiple Myeloma [MM]
排名
無可用數據
各國 Multiple Myeloma Management vs. Multiple Myeloma [MM] 排名比較
比較過去 28 天的 Multiple Myeloma Management 排名趨勢與 Multiple Myeloma [MM]
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Multiple Myeloma Management VS.
Multiple Myeloma [MM]
12月 19, 2024